PKC-activating compounds for the treatment of neurodegenerative diseases Grant US-11820745-B2 United States of America 21 Nov 2023
PKC-activating compounds for the treatment of neurodegenerative diseases Grant US-11390596-B2 United States of America 19 Jul 2022
PKC-activating compounds for the treatment of neurodegenerative diseases Grant US-10696644-B2 United States of America 30 Jun 2020
PKC-activating compounds for the treatment of neurodegenerative diseases Grant US-10323011-B2 United States of America 18 Jun 2019
Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio-alzheimer's… Grant US-9797913-B2 United States of America 24 Oct 2017
METHODS AND COMPOSITIONS FOR TREATING AMYLOID DEPOSITS Application EP-3071240-A4 European Patent Office 11 Oct 2017
NOVEL METHOD FOR THE DETECTION OF PGLU-ABETA PEPTIDES Application WO-2016097305-A1 World Intellectual Property Organisation (WIPO) 23 Jun 2016
Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation Grant US-9188595-B2 United States of America 17 Nov 2015
Esters of DCPLA and methods of treatment using the same Grant US-9163032-B2 United States of America 20 Oct 2015
PKC-activating compounds for the treatment of neurodegenerative diseases Grant US-9119825-B2 United States of America 01 Sep 2015
Stimulus-elicited genomic profile markers of alzheimer's disease Grant US-8822166-B2 United States of America 02 Sep 2014
Method for diagnosing diseases using a protein or degradation product based on half-life Application US-8735085-B2 United States of America 27 May 2014
Fibroblast growth patterns for diagnosis of Alzheimer's disease Grant US-8658134-B2 United States of America 25 Feb 2014
Method of Differentially Diagnosing Dementias Application EP-2437067-A2 European Patent Office 04 Apr 2012
Alzheimer's disease-specific alterations of the Erk1/Erk2 phosphorylation ratio Grant US-7595167-B2 United States of America 29 Sep 2009